# Motif Neurotech **Entity class:** Concept or analytic term **Collection:** [[collections/Neurotech|Neurotech]] ## Definition **Motif Neurotech** is a concept or analytic term. Motif Neurotech was founded by [[wiki/Jacob Robinson|Jacob Robinson]]. Rice faculty founder/CEO; direct personnel continuation from MOANA/N3. Motif Neurotech was founded by [[wiki/Kaiyuan Yang|Kaiyuan Yang]]. Rice faculty co-founder. Motif Neurotech was founded by [[wiki/Sunil Sheth|Sunil Sheth]]. Physician co-founder. The entry centers on the concept's meaning, practical use, and boundaries, together with the examples that make the distinction operational rather than merely verbal. ## Relationships <!-- BEGIN HUMANIZED RELATIONSHIPS 2026-09-11 --> This entry is routed through [[collections/Neurotech|Neurotech]] and [[collections/Consciousness Continuity|Consciousness Continuity]]. Its source context is developed in [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]], [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]], [[articles/The Next Interface Layer|The Next Interface Layer]], and [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]]. Status-qualified source edges are preserved in the terminal Research Edges section. ### People and institutional relationships - **Motif Neurotech** was founded by [[wiki/Jacob Robinson|Jacob Robinson]]. Rice faculty founder/CEO; direct personnel continuation from MOANA/N3. - **Motif Neurotech** was founded by [[wiki/Kaiyuan Yang|Kaiyuan Yang]]. Rice faculty co-founder. - **Motif Neurotech** was founded by [[wiki/Sunil Sheth|Sunil Sheth]]. Physician co-founder. - **Motif Neurotech** was founded by [[wiki/Sameer Sheth|Sameer Sheth]]. Physician co-founder. ### Key Relationships - **Motif Neurotech** is associated with Rice University research / Rice Biotech Launch Pad. - **Motif Neurotech** is associated with [[wiki/Treatment-Resistant Depression|treatment-resistant depression]]. - **Motif Neurotech** is associated with 18.75 million USD. Led by Arboretum Ventures; 2024. - **Motif Neurotech** is associated with [[wiki/Brain Mesh|Brain Mesh]]. Distributed network interface to mesoscale cortical circuits. ### Technology and research relationships - **Motif Neurotech** develops [[wiki/Digitally programmable Over-brain Therapeutic (DOT)|Digitally programmable Over-brain Therapeutic (DOT)]]. Miniature therapeutic brain stimulator. - The source corpus interprets the relationship this way: **Motif Neurotech** is associated with Subsense. Both exploit magnetoelectric physics in neurotechnology, but Motif uses millimeter-scale implanted wireless power/stimulation while Subsense uses nanoparticle-scale distributed transduction. ### Governance, authority, and safeguards - **Motif Neurotech** is associated with [[wiki/FDA authorization to begin first clinical trial|FDA authorization to begin first clinical trial]]. 2026-04-28 Rice report; not commercial approval. ### Funding, business, and licensing - **Motif Neurotech** invested in [[wiki/Arboretum Ventures|Arboretum Ventures]]. Series A investor list. - **Motif Neurotech** invested in [[wiki/KdT Ventures|KdT Ventures]]. Series A investor list. - **Motif Neurotech** invested in [[wiki/Satori Neuro|Satori Neuro]]. Series A investor list. - **Motif Neurotech** invested in [[wiki/Dolby Family Ventures|Dolby Family Ventures]]. Series A investor list. - **Motif Neurotech** invested in [[wiki/re.Mind Capital|re.Mind Capital]]. Series A investor list. - **Motif Neurotech** invested in [[wiki/Divergent Capital|Divergent Capital]]. Series A investor list. - **Motif Neurotech** invested in [[wiki/TMC Venture Fund|TMC Venture Fund]]. Series A investor list. - **Motif Neurotech** invested in [[wiki/PsyMed Ventures|PsyMed Ventures]]. Series A investor list. - **Motif Neurotech** invested in [[wiki/Empath Ventures|Empath Ventures]]. Series A investor list. - **Motif Neurotech** invested in [[wiki/Capital Factory|Capital Factory]]. Series A investor list. ### Additional Documented Relationships - The source corpus interprets the relationship this way: **Motif Neurotech** is associated with [[wiki/Subsense BCI|Subsense BCI]]. Both exploit magnetoelectric physics in neurotechnology. but Motif uses millimeter-scale implanted wireless power/stimulation while Subsense uses nanoparticle-scale distributed transduction. - Distributed network interface to mesoscale cortical circuits. <!-- END HUMANIZED RELATIONSHIPS 2026-09-11 --> ## Related Work in the Corpus <!-- BEGIN HUMANIZED CORPUS ROUTES 2026-09-11 --> - In [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]], **IX. The escape from the electrode** provides the narrative context for **Motif Neurotech**: The cleanest lineage in the ecosystem runs from Rice and Jacob Robinson through N3's MOANA — diffuse optical read paired with magnetic and magnetogenetic write in a multimodal closed-loop architecture — into Motif Neurotech,… <!-- END HUMANIZED CORPUS ROUTES 2026-09-11 --> ## Research Edges <!-- BEGIN NEUROTECH RELATIONSHIP GRAPH 2026-09-10 --> #### Master relationship graph patch — 2026-09-10 **Collection:** [[collections/Neurotech|Neurotech]] **Relationship source:** [[research/Neurotechnology Ecosystem Relationship Graph - 2026-09-10|Neurotechnology Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] #### Outgoing typed edges - **Edge 166 — `founded_by` → [[wiki/Jacob Robinson|Jacob Robinson]]** — **VERIFIED**; evidence `MOTIF_2024`, `MOTIF_SERIESA`. Rice faculty founder/CEO; direct personnel continuation from MOANA/N3. - **Edge 167 — `founded_by` → [[wiki/Kaiyuan Yang|Kaiyuan Yang]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Rice faculty co-founder. - **Edge 168 — `founded_by` → [[wiki/Sunil Sheth|Sunil Sheth]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Physician co-founder. - **Edge 169 — `founded_by` → [[wiki/Sameer Sheth|Sameer Sheth]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Physician co-founder. - **Edge 170 — `spun_out_of` → Rice University research / Rice Biotech Launch Pad** — **VERIFIED**; evidence `MOTIF_2024`, `MOTIF_SERIESA`. - **Edge 172 — `develops` → [[wiki/Digitally Programmable Over-Brain Therapeutic|Digitally programmable Over-brain Therapeutic (DOT)]]** — **VERIFIED**; evidence `MOTIF_2024`, `MOTIF_TRIAL_2026`. Miniature therapeutic brain stimulator. - **Edge 175 — `clinical_indication` → [[wiki/Treatment-Resistant Depression|treatment-resistant depression]]** — **VERIFIED**; evidence `MOTIF_TRIAL_2026`, `MOTIF_SERIESA`. - **Edge 176 — `regulatory_milestone` → FDA authorization to begin first clinical trial** — **VERIFIED**; evidence `MOTIF_TRIAL_2026`. 2026-04-28 Rice report; not commercial approval. - **Edge 177 — `Series_A` → 18.75 million USD** — **VERIFIED**; evidence `MOTIF_SERIESA`. Led by Arboretum Ventures; 2024. - **Edge 178 — `investor` → [[wiki/Arboretum Ventures|Arboretum Ventures]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 179 — `investor` → [[wiki/KdT Ventures|KdT Ventures]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 180 — `investor` → [[wiki/Satori Neuro|Satori Neuro]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 181 — `investor` → [[wiki/Dolby Family Ventures|Dolby Family Ventures]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 182 — `investor` → [[wiki/re.Mind Capital|re.Mind Capital]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 183 — `investor` → [[wiki/Divergent Capital|Divergent Capital]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 184 — `investor` → [[wiki/TMC Venture Fund|TMC Venture Fund]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 185 — `investor` → [[wiki/PsyMed Ventures|PsyMed Ventures]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 186 — `investor` → [[wiki/Empath Ventures|Empath Ventures]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 187 — `investor` → [[wiki/Capital Factory|Capital Factory]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 188 — `ARIA_project` → [[wiki/Brain Mesh|Brain Mesh]]** — **VERIFIED**; evidence `ARIA_PROJECTS`, `ARIA_RICE`. Distributed network interface to mesoscale cortical circuits. - **Edge 192 — `technical_comparison` → [[wiki/Subsense BCI|Subsense]]** — **ANALYTIC**; evidence `MOTIF_2024`, `SUB_TECH`. Both exploit magnetoelectric physics in neurotechnology, but Motif uses millimeter-scale implanted wireless power/stimulation while Subsense uses nanoparticle-scale distributed transduction. <!-- END NEUROTECH RELATIONSHIP GRAPH 2026-09-10 --> <!-- BEGIN CONSCIOUSNESS MAPPING TRANSFER RELATIONSHIP GRAPH 2026-09-10 --> #### Consciousness mapping and transfer graph patch — 2026-09-10 **Collections:** [[collections/Neurotech|Neurotech]] · [[collections/Consciousness Continuity|Consciousness Continuity]] **Relationship source:** [[research/Consciousness Mapping and Transfer Ecosystem Relationship Graph - 2026-09-10|Consciousness Mapping and Transfer Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] · [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] #### Outgoing typed edges - **Edge 166 — `founded_by` → [[wiki/Jacob Robinson|Jacob Robinson]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_2024`, `MOTIF_SERIESA`. Rice faculty founder/CEO; direct personnel continuation from MOANA/N3. - **Edge 167 — `founded_by` → [[wiki/Kaiyuan Yang|Kaiyuan Yang]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Rice faculty co-founder. - **Edge 168 — `founded_by` → [[wiki/Sunil Sheth|Sunil Sheth]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Physician co-founder. - **Edge 169 — `founded_by` → [[wiki/Sameer Sheth|Sameer Sheth]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Physician co-founder. - **Edge 170 — `spun_out_of` → Rice University research / Rice Biotech Launch Pad** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_2024`, `MOTIF_SERIESA`. - **Edge 172 — `develops` → [[wiki/Digitally programmable Over-brain Therapeutic (DOT)|Digitally programmable Over-brain Therapeutic (DOT)]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_2024`, `MOTIF_TRIAL_2026`. Miniature therapeutic brain stimulator. - **Edge 175 — `clinical_indication` → [[wiki/Treatment-Resistant Depression|treatment-resistant depression]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_TRIAL_2026`, `MOTIF_SERIESA`. - **Edge 176 — `regulatory_milestone` → [[wiki/FDA authorization to begin first clinical trial|FDA authorization to begin first clinical trial]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_TRIAL_2026`. 2026-04-28 Rice report; not commercial approval. - **Edge 177 — `Series_A` → 18.75 million USD** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Led by Arboretum Ventures; 2024. - **Edge 178 — `investor` → [[wiki/Arboretum Ventures|Arboretum Ventures]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 179 — `investor` → [[wiki/KdT Ventures|KdT Ventures]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 180 — `investor` → [[wiki/Satori Neuro|Satori Neuro]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 181 — `investor` → [[wiki/Dolby Family Ventures|Dolby Family Ventures]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 182 — `investor` → [[wiki/re.Mind Capital|re.Mind Capital]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 183 — `investor` → [[wiki/Divergent Capital|Divergent Capital]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 184 — `investor` → [[wiki/TMC Venture Fund|TMC Venture Fund]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 185 — `investor` → [[wiki/PsyMed Ventures|PsyMed Ventures]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 186 — `investor` → [[wiki/Empath Ventures|Empath Ventures]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 187 — `investor` → [[wiki/Capital Factory|Capital Factory]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 188 — `ARIA_project` → [[wiki/Brain Mesh|Brain Mesh]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `ARIA_PROJECTS`, `ARIA_RICE`. Distributed network interface to mesoscale cortical circuits. - **Edge 192 — `technical_comparison` → [[wiki/Subsense BCI|Subsense]]** — **PRIOR_NEUROTECH_ANALYTIC**; evidence `MOTIF_2024`, `SUB_TECH`. Both exploit magnetoelectric physics in neurotechnology, but Motif uses millimeter-scale implanted wireless power/stimulation while Subsense uses nanoparticle-scale distributed transduction. <!-- END CONSCIOUSNESS MAPPING TRANSFER RELATIONSHIP GRAPH 2026-09-10 -->